The challenge for the practitioner is to balance incomplete evidence about efficacy of medications in frail older people against the problems related to adverse drug reactions without denying people potentially valuable pharmacotherapeutic interventions. Prescribers need to be diligent in reviewing medications periodically as well as when new medications are being considered. Review of updated explicit criteria is essential to understand and prescribe appropriately in this special population.